Objective Capital - research you can trust!

objective corporate research
what is corporate research?


		Download our latest Newsletter


	Objective is a leader in researching small and mid-cap UK stocks Read More RSS feeds: All Headlines


	Objective Capital to be a platinum sponsor of 2nd Annual Global Capital Forum 2008, London Oct, 2008 Objective Capital to host New York presentation on 'The future of Biofuels - Jatropha and Algae?' Sept, 2008 Objective Capital partners Sach's 8th Biotech in Europe Investor Forum 2008, Zurich Sept, 2008 Objective Capital hosts New York presentation on mining in 'Albania - revisiting old frontiers' July, 2008 Join us at the Objective Capital Small Cap Forum in London on 20 June 2008 June, 2008 Meet Objective Capital at the 2008 World Resource Show, Vancouver June, 2008 Join us at Objective Capital's series of region workshops on the role of research for AIM companies London 6 June, 2008 Bristol 13 June, 2008 Leeds 20 June, 2008 Join us at the Objective Capital Small Cap Forum in London on 14 March 2008 March, 2008 Objective Capital, gold sponsor to the PDAC Convention and Investor Exhibition 2008, Toronto March, 2008 Objective Capital to sponsor North of 60, the leading conference for northern resource projects Feb, 2008 Meet Objective Capital at the 2008 Vancouver Gold Show, Vancouver Jan, 2008 Objective Capital invited to lead delegation of junior mining companies to MENA-EX 2008, Saudi Arabia Dec, 2007 Objective Capital to be gold sponsor of Mines & Money 2007, London Nov, 2007 Meet Objective Capital at the 2007 San Francisco Hard Asset Mining Show Oct, 2007 Objective Capital to present at the London Stock Exchange's 4th annual FinLab for CIS companies Sept, 2007 Objective Capital to be a platinum sponsor of Global Capital Forum 2007, London August, 2007 Objective Capital sponsors Nunavut 2007, the leading conference for Nunavut based resource companies Feb, 2007 Contact us for more details Important Information: see our disclaimer





	e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons e-Therapeutics’ brand of ‘success-predictive’ drug discovery, based on bioinformatics and the analysis of complex biological systems, holds the potential, if clinically validated, to open up entirely new horizons in the treatment of complex, intractable or poorly treated diseases. Read More \| Previous Reports Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy Nov 07, 2008 Great Western Minerals is pressing ahead with exploration at its Hoidas Lake rare earth elements deposit in northern Saskatchewan. It is also drilling on a second rare earth project, in Utah USA. The company recently acquired Less Common Metals and it continues development of Great Western Technologies Inc. Both companies focus on development and marketing of value-added rare earth alloys for the aerospace, automotive and high-technology sectors. Read More \| Previous Reports LiDCO (LID.L) - half year results show early signs of being on track Oct 30, 2008 LiDCO’s half year results reported today show some early glimpses of what the future might be like. Headline revenues were up only a modest 3% but this masks underlying dynamics which while early are highly encouraging. Read More \| Previous Reports Sofame Technologies (SDW.V) - reducing costs, curbing fuel usage and carbon reduction is a powerful combination Oct 29, 2008 Sofame custom-engineered and manufactured systems improve the efficiency of existing gas fired boilers, reducing fuel costs and greenhouse gas emissions. The increase in energy prices has made such savings more attractive. New management has overhauled business practices and has set extremely ambitious sales targets. Read More \| Previous Reports York Pharma (YRK.L) - acquisition of the Solvay product line is a company-transforming event Oct 17, 2008 Although it has taken some time to complete, the acquisition of Solvay’s topical Derm product line has accelerated York’s push to achieve the status of a self‑sustaining Specialty Pharma company. The valuation reduction is notable but it brings the company much closer to profitability and a more certain future in this volatile capital market period. Read More \| Previous Reports





	e-Therapeutics (ETX.L) - ‘success-predictive’ drug discovery may be the key to new treatment horizons Nov 18, 2008 \| Previous NioGold Mining Corp (NOX.V) - more encouraging assays Nov 12, 2008 \| Previous Great Western Minerals (GWG.V) - pressing ahead with mine-to-market strategy Nov 07, 2008 \| Previous LiDCO (LID.L) - half year results show early signs of being on track Oct 30, 2008 \| Previous York Pharma (YRK.L) - acquires CellTran: augmenting the bag of 'goodies' Oct 29, 2008 \| Previous Sofame Technologies (SDW.V) - reducing costs, curbing fuel usage and carbon reduction is a powerful combination Oct 29, 2008 \| Previous Columbia Yukon Explorations (CYU.V) - encouragement new assays Oct 29, 2008 \| Previous Playfair Mining (PLY.V) - assays from ten holes Oct 24, 2008 \| Previous York Pharma (YRK.L) - acquisition of the Solvay product line is a company-transforming event Oct 17, 2008 \| Previous Columbia Yukon Explorations (CYU.V) - mineralised zone continues to expand Oct 10, 2008 \| Previous Balkan Resources (private) - exploration junior with sharp focus on Albanian Oct 08, 2008 \| Previous Albania - revisiting old frontiers Oct 08, 2008 \| Previous JAB Resources (private) - defining a chromite project in Albania Oct 08, 2008 \| Previous NioGold Mining Corp (NOX.V) - acquiring option on contiguous gold property Oct 06, 2008 \| Previous Columbia Yukon Explorations (CYU.V) - encouraging assay and metallurgical results Sep 26, 2008 \| Previous

	FTSE 100 UK MID CAPS (FTSE 250) UK SMALL CAPS AIM




	Albania - revisiting old frontiers Oct 08, 2008 \| Previous Reports Balkan Resources (private) - exploration junior with sharp focus on Albanian Oct 08, 2008 \| Previous Reports JAB Resources (private) - defining a chromite project in Albania Oct 08, 2008 \| Previous Reports SilverCrest Mining (SVL.V) - revised valuation of C$1.32 per share Sep 22, 2008 \| Previous Reports London Capital (LCG.L) - recent results confirm our forecasts Aug 12, 2008 \| Previous Reports Tirex Resources (TXX.V) - continuing the first modern exploration programme in Albania Aug 08, 2008 \| Previous Reports Columbia Yukon Explorations (CYU.V) - promising undervalued molybdenum project Aug 06, 2008 \| Previous Reports London Capital (LCG.L) - recent results confirm our forecasts Aug 12, 2008 \| Previous Reports Tirex Resources (TXX.V) - continuing the first modern exploration programme in Albania Aug 08, 2008 \| Previous Reports Columbia Yukon Explorations (CYU.V) - promising undervalued molybdenum project Aug 06, 2008 \| Previous Reports Conroy Diamonds and Gold (CDG.L) - substantially upgraded to resource and valuation Jul 29, 2008 \| Previous Reports KleenAir Systems (KSI.L) - a combination of problems – not all their own making Jul 28, 2008 \| Previous Reports Soho Resources (SOH.V) - aggressive drill programme has put it ahead of schedule Jul 02, 2008 \| Previous Reports RATINGS NEWS OCCASIONAL PAPERS Albania - revisting old frontiers October, 2008 The rise of independent research (IR Magazine) March, 2006 Presentation to 2005 AIM Conference Sept 26, 2005 The Role of Sponsored Research June 22, 2005 Objective's Corporate Brochure July 01, 2004

Objective Capital's Contact Information
Partnership, sales and product inquiries: marketing@objectivecapital.co.uk
Media services and conference requests: PR@objectivecapital.co.uk
Subscription and customer service issues: service@objectivecapital.co.uk
Comments or opinions on our analysis: analysis@objectivecapital.co.uk

By mail: 2nd floor, 145 St John Street, London EC1V 4PY, United Kingdom
Sales & Marketing: 11-12 Tokenhouse Yard, London EC2R 7AS, United Kingdom
ph +44-(0)870-080 2965 fax +44-(0)870-116 0839